Anbio Biotechnology Class A Ordinary Shares (NNNN) — Defensive Interval Ratio
Anbio Biotechnology Class A Ordinary Shares (NNNN) has a Defensive Interval Ratio of 32377 days as of March 2026. Defensive assets of $7.79 Million (cash $-, short-term investments $4.13 Million, receivables $3.66 Million) cover 32377 days of daily cash needs of $240.65/day. See NNNN working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Anbio Biotechnology Class A Ordinary Shares Defensive Interval Ratio (2021–2025)
This chart shows how Anbio Biotechnology Class A Ordinary Shares's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 32377 days, meaning defensive assets of $7.79 Million can fund 32377 days of operations without new revenue. See Anbio Biotechnology Class A Ordinary Sha balance sheet independence to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Anbio Biotechnology Class A Ordinary Shares (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for Anbio Biotechnology Class A Ordinary Shares from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of Anbio Biotechnology Class A Ordinary Sha.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 32377 days | $7.79 Million | $240.65/day | $- | $4.13 Million | ▲ +32152 days |
| 2024 | 225 days | $1.06 Million | $4.74K/day | $- | $0.00 | ▼ -468 days |
| 2023 | 693 days | $1.88 Million | $2.72K/day | $- | $0.00 | ▲ +287 days |
| 2022 | 406 days | $1.57 Million | $3.87K/day | $- | $1.57 Million | ▲ +296 days |
| 2021 | 110 days | $717.50K | $6.52K/day | $- | $0.00 | — |